Cryo-Cell International, Inc.
CCEL
Last
$4.36
Day
+4.6%
1y
-6.9%
5y
-70.6%
52w
-14.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-10-2111d
EMA 21
4.07
EMA 50
4.00
EMA 200
3.90
20d high
-11.7%
5y high
-70.6%
5y range
13th
Positions held
Your positionsCCEL isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
8
Hold
watch
Signal
Neutral
Target
$5.35
Stop
$3.58
Stop distance
17.9%
Target vs last
+22.7%
Fundamentals
| Market cap | $33.62M | Enterprise value | $39.42M | Trailing P/E | — | Forward P/E | 208.50 |
| PEG | 1.34 | Price / book | -1.89 | Beta | 0.59 | Dividend yield | 0.00% |
| Revenue growth | -1.9% | Earnings growth | 72.1% | Gross margin | 63.9% | Operating margin | 15.4% |
| Profit margin | -7.9% | ROE | — | ROA | -0.1% | Debt / equity | — |
| Current ratio | 0.71 | Free cash flow | $1.52M | Analyst recommendation | none | Mean target | — |
| 52w high | $4.90 | 52w low | $2.72 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|
| Revenue | $7.8M | $7.7M | $7.8M | $7.9M | $8.0M |
| Op margin | 15.4% | 10.0% | 5.0% | 18.8% | 13.3% |
| Net income | $0.6M | $0.0M | -$3.8M | $0.4M | $0.3M |
| Gross margin | 78.4% | 78.4% | 77.9% | 76.6% | 75.1% |
| Gross profit | $6.1M | $6.0M | $6.1M | $6.1M | $6.0M |
| Operating income | $1.2M | $0.8M | $0.4M | $1.5M | $1.1M |
- Revenue +1% vs prior quarter ($7.8M vs $7.7M).
- Gross margin 78.4% (was 78.4% prior quarter).
- Operating margin expanded to 15.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $31.6M | $32.0M | $31.3M | $30.3M | — |
| Op margin | 15.3% | 11.8% | 11.1% | 14.7% | — |
| Net income | -$2.4M | $0.4M | -$9.5M | $2.8M | — |
| Gross margin | 76.6% | 75.2% | 73.2% | 71.0% | — |
| Gross profit | $24.2M | $24.0M | $23.0M | $21.5M | — |
| Operating income | $4.8M | $3.8M | $3.5M | $4.5M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsCCEL · daily+0.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin